• Does Spaceflight Speed Up Tissue Maturation?
    Nov 17 2026

    If spaceflight makes human tissue mature faster, do the cells actually work better, or do they just look more mature by some measures?

    In this debate, a cardiac scientist and a clinician-scientist compare five studies of human stem-cell-derived tissues. Neural organoids grown on the ISS expressed more maturation-associated genes, but that study did not establish electrical maturation. Simulated microgravity improved some measures of calcium handling in cardiomyocytes, while separate flight studies reported slower calcium clearance or weaker contractions. The studies used different models, exposure times, and endpoints; they do not directly contradict one another.

    The revised conjecture: orbital exposure may alter the pace of specific aspects of maturation, but the effect depends on cell type, developmental stage, and what we measure. The next test: compare matched tissues on Earth and aboard the ISS, including an onboard 1g control, and measure both gene expression and function during exposure and recovery. The evidence is preclinical.

    Audio credit: AI-generated voices.

    Papers discussed:
    • Marotta et al. ISS neural organoids. Stem Cells Translational Medicine (2024). https://doi.org/10.1093/stcltm/szae070
    • Mair et al. ISS heart-on-a-chip. PNAS (2024). https://doi.org/10.1073/pnas.2404644121
    • Wnorowski et al. ISS cardiomyocyte structure and function. Stem Cell Reports (2019). https://doi.org/10.1016/j.stemcr.2019.10.006
    • Baio et al. ISS cardiovascular progenitor cells. npj Microgravity (2018). https://doi.org/10.1038/s41526-018-0048-x
    • Simulated microgravity and hiPSC-derived cardiomyocyte maturation. Scientific Reports (2024). https://doi.org/10.1038/s41598-024-52453-1

    Mehr anzeigen Weniger anzeigen
    21 Min.
  • What Does Heat Change About the Heart?
    Nov 17 2026

    This episode features AI-generated hosts from Google NotebookLM.

    Does warming itself help end the newborn heart’s ability to regenerate, or are warming and loss of repair parallel effects of postnatal hormonal changes? This debate separates three timescales: the pacemaker’s immediate response to heat, temperature-dependent developmental tempo in fish embryos, and the postnatal changes associated with loss of cardiac regeneration in mice. The studies don’t establish that one mechanism explains all three.

    Papers discussed:
    • HCN4 channels sense temperature and determine heart rate responses to heat. Nature Communications (2025). https://doi.org/10.1038/s41467-025-57358-9
    • Uncovering developmental time and tempo using deep learning. Nature Methods (2023). https://doi.org/10.1038/s41592-023-02083-8
    • Adrenergic-thyroid hormone interactions drive postnatal thermogenesis and loss of mammalian heart regenerative capacity. Circulation (2021). https://doi.org/10.1161/CIRCULATIONAHA.121.054846
    • Evidence for hormonal control of heart regenerative capacity during endothermy acquisition. Science (2019). https://doi.org/10.1126/science.aar2038

    #CardiacFibrosis #CarT #FAP

    Mehr anzeigen Weniger anzeigen
    22 Min.
  • Redirected T Cells Target Cardiac Fibrosis
    May 9 2025

    Aghajanian, H., Kimura, T., Rurik, J.G. et al. Targeting cardiac fibrosis with engineered T cells. Nature 573, 430–433 (2019). https://doi.org/10.1038/s41586-019-1546-z

    Published: 11 September 2019 by Jonathan A. Epstein Group at UPenn

    Abstract: Fibrosis is observed in nearly every form of myocardial disease1. Upon injury, cardiac fibroblasts in the heart begin to remodel the myocardium by depositing excess extracellular matrix, resulting in increased stiffness and reduced compliance of the tissue. Excessive cardiac fibrosis is an important factor in the progression of various forms of cardiac disease and heart failure2. However, clinical interventions and therapies that target fibrosis remain limited3. Here we demonstrate the efficacy of redirected T cell immunotherapy to specifically target pathological cardiac fibrosis in mice. We find that cardiac fibroblasts that express a xenogeneic antigen can be effectively targeted and ablated by adoptive transfer of antigen-specific CD8+ T cells. Through expression analysis of the gene signatures of cardiac fibroblasts obtained from healthy and diseased human hearts, we identify an endogenous target of cardiac fibroblasts—fibroblast activation protein. Adoptive transfer of T cells that express a chimeric antigen receptor against fibroblast activation protein results in a significant reduction in cardiac fibrosis and restoration of function after injury in mice. These results provide proof-of-principle for the development of immunotherapeutic drugs for the treatment of cardiac disease.

    #CardiacFibrosis #CarT #FAP

    Mehr anzeigen Weniger anzeigen
    12 Min.
  • Selective inhibition of stromal mechanosensing suppresses cardiac fibrosis
    May 8 2025

    Cho, S., Rhee, S., Madl, C.M. et al. Selective inhibition of stromal mechanosensing suppresses cardiac fibrosis. Nature (2025). https://doi.org/10.1038/s41586-025-08945-9

    Published: 30 April 2025 from Joseph C. Wu Group at Stanford University, School of Medicine

    Abstract: Matrix-derived biophysical cues are known to regulate the activation of fibroblasts and their subsequent transdifferentiation into myofibroblasts, but whether modulation of these signals can suppress fibrosis in intact tissues remains unclear, particularly in the cardiovascular system. Here we demonstrate across multiple scales that inhibition of matrix mechanosensing in persistently activated cardiac fibroblasts potentiates—in concert with soluble regulators of the TGFβ pathway—a robust transcriptomic, morphological and metabolic shift towards quiescence. By conducting a meta-analysis of public human and mouse single-cell sequencing datasets, we identify the focal-adhesion-associated tyrosine kinase SRC as a fibroblast-enriched mechanosensor that can be targeted selectively in stromal cells to mimic the effects of matrix softening in vivo. Pharmacological inhibition of SRC by saracatinib, coupled with TGFβ suppression, induces synergistic repression of key profibrotic gene programs in fibroblasts, characterized by a marked inhibition of the MRTF–SRF pathway, which is not seen after treatment with either drug alone. Importantly, the dual treatment alleviates contractile dysfunction in fibrotic engineered heart tissues and in a mouse model of heart failure. Our findings point to joint inhibition of SRC-mediated stromal mechanosensing and TGFβ signalling as a potential mechanotherapeutic strategy for treating cardiovascular fibrosis.

    #CardiacFibrosis #CarT #FAP

    Mehr anzeigen Weniger anzeigen
    17 Min.